181 related articles for article (PubMed ID: 23677114)
1. Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome.
Chang AL; Atwood SX; Tartar DM; Oro AE
JAMA Dermatol; 2013 May; 149(5):639-41. PubMed ID: 23677114
[No Abstract] [Full Text] [Related]
2. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.
Wolfe CM; Green WH; Cognetta AB; Hatfield HK
Dermatol Surg; 2012 Nov; 38(11):1863-6. PubMed ID: 22805146
[No Abstract] [Full Text] [Related]
3. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome.
Tang JY; Mackay-Wiggan JM; Aszterbaum M; Yauch RL; Lindgren J; Chang K; Coppola C; Chanana AM; Marji J; Bickers DR; Epstein EH
N Engl J Med; 2012 Jun; 366(23):2180-8. PubMed ID: 22670904
[TBL] [Abstract][Full Text] [Related]
4. 9q22.3 Microdeletion Syndrome with Multiple Basal Cell Carcinomas Treated with Vismodegib: Three Key Messages in One Patient.
Kieny A; Kremer V; Scheidecker S; Lipsker D
Acta Derm Venereol; 2018 Feb; 98(2):287-288. PubMed ID: 29057423
[No Abstract] [Full Text] [Related]
5. Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.
Ally MS; Wysong A; Tang JY; Aasi S
Dermatol Surg; 2013 Sep; 39(9):1413-4. PubMed ID: 23682843
[No Abstract] [Full Text] [Related]
6. Histologic changes in basal cell carcinoma after treatment with vismodegib.
Aldabagh B; Yu J; Perkocha LA; Arron S
Dermatol Surg; 2013 Nov; 39(11):1703-5. PubMed ID: 23879864
[No Abstract] [Full Text] [Related]
7. Vismodegib in advanced basal-cell carcinoma.
Henkin RI
N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
[No Abstract] [Full Text] [Related]
8. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Tang JY; Ally MS; Chanana AM; Mackay-Wiggan JM; Aszterbaum M; Lindgren JA; Ulerio G; Rezaee MR; Gildengorin G; Marji J; Clark C; Bickers DR; Epstein EH
Lancet Oncol; 2016 Dec; 17(12):1720-1731. PubMed ID: 27838224
[TBL] [Abstract][Full Text] [Related]
9. Patient with Gorlin syndrome and metastatic basal cell carcinoma refractory to smoothened inhibitors.
Zhu GA; Li AS; Chang AL
JAMA Dermatol; 2014 Aug; 150(8):877-9. PubMed ID: 24898076
[TBL] [Abstract][Full Text] [Related]
10. Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp.
Tauber G; Pavlovsky L; Fenig E; Hodak E
J Am Acad Dermatol; 2015 Nov; 73(5):799-801. PubMed ID: 26320385
[TBL] [Abstract][Full Text] [Related]
11. Effect of Calcium Channel Blockade on Vismodegib-Induced Muscle Cramps.
Ally MS; Tang JY; Lindgren J; Acosta-Raphael M; Rezaee M; Chanana AM; Epstein EH
JAMA Dermatol; 2015 Oct; 151(10):1132-4. PubMed ID: 26200175
[No Abstract] [Full Text] [Related]
12. Acquisition of Drug Resistance in Basal Cell Nevus Syndrome Tumors through Basal to Squamous Cell Carcinoma Transition.
Jussila AR; Haensel D; Gaddam S; Oro AE
J Invest Dermatol; 2024 Jun; 144(6):1368-1377.e6. PubMed ID: 38157930
[TBL] [Abstract][Full Text] [Related]
13. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
14. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
[TBL] [Abstract][Full Text] [Related]
15. Intermittent Vismodegib Therapy in Basal Cell Nevus Syndrome.
Yang X; Dinehart SM
JAMA Dermatol; 2016 Feb; 152(2):223-4. PubMed ID: 26509945
[No Abstract] [Full Text] [Related]
16. Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series.
Wong C; Poblete-Lopez C; Vidimos A
J Am Acad Dermatol; 2020 Jun; 82(6):1539-1542. PubMed ID: 32092372
[No Abstract] [Full Text] [Related]
17. Severe Rheumatoid Arthritis Developing in Conjunction with Gorlin Syndrome.
Scott JF; Bordeaux JS
J Rheumatol; 2016 Jul; 43(7):1447-9. PubMed ID: 27371652
[No Abstract] [Full Text] [Related]
18. Complete response of a locally advanced basosquamous carcinoma with vismodegib treatment.
Sahuquillo-Torralba A; Llavador-Ros M; Caballero-Daroqui J; Botella-Estrada R
Indian J Dermatol Venereol Leprol; 2019; 85(5):549-552. PubMed ID: 31389370
[No Abstract] [Full Text] [Related]
19. Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC).
Kwon GP; Ally MS; Bailey-Healy I; Oro AE; Kim J; Chang AL; Aasi S; Tang JY
J Am Acad Dermatol; 2016 Jul; 75(1):213-5. PubMed ID: 27317518
[No Abstract] [Full Text] [Related]
20. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
